Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro activities of new beta-lactam antibiotics against Acinetobacter spp.

Literature DB >> 6638992

In vitro activities of new beta-lactam antibiotics against Acinetobacter spp.

I Garcia, V Fainstein, B LeBlanc, G P Bodey.

Abstract

The in vitro activities of new beta-lactam antibiotics was studied and compared with those of other known agents against 51 clinical isolates of Acinetobacter calcoaceticus subsp. anitratus and 23 isolates of A. calcoaceticus subsp. lwoffi. Of the new beta-lactam antibiotics, imipemide (N-formimidoyl thienamycin), ceftazidime, ceftizoxime, ceftriaxone, and piperacillin demonstrated good activities. The minimal inhibitory concentrations for A. calcoaceticus subsp. lwoffi were lower than those obtained for A. calcoaceticus subsp. anitratus.

Entities: Chemical Species

Mesh：

Substances：

Year: 1983 PMID： 6638992 PMCID： PMC185157 DOI： 10.1128/AAC.24.2.297

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

8 in total

1. Piperacillin: in vitro evaluation.

Authors: G P Bodey; B Le Blanc
Journal: Antimicrob Agents Chemother Date: 1978-07 Impact factor: 5.191

Review 2. The new beta-lactamase-stable cephalosporins.

Authors: H C Neu
Journal: Ann Intern Med Date: 1982-09 Impact factor: 25.391

3. Mimeae: opportunistic pathogens.A review of infections in a cancer hospital.

Authors: G S Green; R H Johnson; J A Shively
Journal: JAMA Date: 1965-12-06 Impact factor: 56.272

4. A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.

Authors: W Cullmann; W Opferkuch; M Stieglitz; U Werkmeister
Journal: Antimicrob Agents Chemother Date: 1982-08 Impact factor: 5.191

5. Comparative in vitro study of temocillin (BRL 17421), a new penicillin.

Authors: R Bolivar; S S Weaver; G P Bodey
Journal: Antimicrob Agents Chemother Date: 1982-04 Impact factor: 5.191

6. Comparative in vitro study in new cephalosporins.

Authors: G P Bodey; V Fainstein; A M Hinkle
Journal: Antimicrob Agents Chemother Date: 1981-08 Impact factor: 5.191

7. Infections with Acinetobacter calcoaceticus (Herellea vaginicola): clinical and laboratory studies.

Authors: R H Glew; R C Moellering; L J Kunz
Journal: Medicine (Baltimore) Date: 1977-03 Impact factor: 1.889

Review 8. Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.

Authors: G M Eliopoulos; R C Moellering
Journal: Ann Intern Med Date: 1982-11 Impact factor: 25.391

8 in total

11 in total

1. Antimicrobial drug susceptibility of clinical isolates of Acinetobacter species (A. baumannii, A. haemolyticus, genospecies 3, and genospecies 6).

Authors: W H Traub; M Spohr
Journal: Antimicrob Agents Chemother Date: 1989-09 Impact factor: 5.191

Review 2. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors: E Bergogne-Bérézin; K J Towner
Journal: Clin Microbiol Rev Date: 1996-04 Impact factor: 26.132

3. Antibacterial characteristics of YTR 830, a sulfone beta-lactamase inhibitor, compared with those of clavulanic acid and sulbactam.

Authors: F Moosdeen; J D Williams; S Yamabe
Journal: Antimicrob Agents Chemother Date: 1988-06 Impact factor: 5.191

4. Enzymatic profile of clinical isolates of Acinetobacter calcoaceticus.

Authors: C L Poh; G K Loh
Journal: Med Microbiol Immunol Date: 1985 Impact factor: 3.402

5. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil.

Authors: Libera M Dalla-Costa; Juliana M Coelho; Helena A P H M Souza; Maria E S Castro; Christiane J N Stier; Karin L Bragagnolo; Alvaro Rea-Neto; Sergio R Penteado-Filho; David M Livermore; Neil Woodford
Journal: J Clin Microbiol Date: 2003-07 Impact factor: 5.948

Review 6. Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors: D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal: Drugs Date: 1984-06 Impact factor: 9.546

7. Comparison of susceptibility of gentamicin-resistant and -susceptible "Acinetobacter anitratus" to 15 alternative antibiotics.

Authors: H G Stiver; K H Bartlett; A W Chow
Journal: Antimicrob Agents Chemother Date: 1986-10 Impact factor: 5.191

Review 8. Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors: S P Clissold; P A Todd; D M Campoli-Richards
Journal: Drugs Date: 1987-03 Impact factor: 9.546

9. In vitro susceptibility of Acinetobacter species to various antimicrobial agents.

Authors: K V Rolston; G P Bodey
Journal: Antimicrob Agents Chemother Date: 1986-11 Impact factor: 5.191

Review 10. Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors: D M Richards; R C Heel
Journal: Drugs Date: 1985-04 Impact factor: 9.546